Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian P Bates

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Cell|August 2, 2016
UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the ProteasomeRoland Hjerpe, John S Bett, Matthew J Keuss, et al.
Diabetes|November 6, 2008
Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's diseaseBronwen Martin, Erin Golden, Olga D Carlson, et al.
Brain : a Journal of Neurology|July 6, 2022
Alternative processing of human HTT mRNA with implications for Huntington's disease therapeuticsSandra Fienko, Christian Landles, Kirupa Sathasivam, et al.
The EMBO Journal|August 7, 2020
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease modelsRamanath Narayana Hegde, Anass Chiki, Lara Petricca, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Brain : a Journal of Neurology|February 22, 2024
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's diseaseSarah G Aldous, Edward J Smith, Christian Landles, et al.
Brain Communications|September 21, 2020
Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease ModelChristian Landles, Rebecca E Milton, Nadira Ali, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseaseEmma Hockly, Victoria M Richon, Benjamin Woodman, et al.
Human Molecular Genetics|September 27, 2005
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's diseaseCaroline L Benn, Christian Landles, He Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 25, 2020
Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunctionRhia Ghosh, Alison Wood-Kaczmar, Lucianne Dobson, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Cell|August 2, 2016
UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the ProteasomeRoland Hjerpe, John S Bett, Matthew J Keuss, et al.
Diabetes|November 6, 2008
Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's diseaseBronwen Martin, Erin Golden, Olga D Carlson, et al.
Brain : a Journal of Neurology|July 6, 2022
Alternative processing of human HTT mRNA with implications for Huntington's disease therapeuticsSandra Fienko, Christian Landles, Kirupa Sathasivam, et al.
The EMBO Journal|August 7, 2020
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease modelsRamanath Narayana Hegde, Anass Chiki, Lara Petricca, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Brain : a Journal of Neurology|February 22, 2024
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's diseaseSarah G Aldous, Edward J Smith, Christian Landles, et al.
Brain Communications|September 21, 2020
Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease ModelChristian Landles, Rebecca E Milton, Nadira Ali, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseaseEmma Hockly, Victoria M Richon, Benjamin Woodman, et al.
Human Molecular Genetics|September 27, 2005
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's diseaseCaroline L Benn, Christian Landles, He Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 25, 2020
Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunctionRhia Ghosh, Alison Wood-Kaczmar, Lucianne Dobson, et al.
Pageof 15